---All---
  • ---All---
  • Accession
  • Catalog #

Androgen receptor AntibodyMouse Monoclonal Antibody to Androgen receptor

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AO1343a 0.1ml 400 ul 7-10 days $ 325.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

Androgen receptor Antibody - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP10275
Other AccessionNP_001011645.1
ReactivityHuman
IsotypeMouse IgG1
Clone Names2H8
Calculated MW98989 Da

Androgen receptor Antibody - Additional info

Gene ID 367
Other Names
NR3C4; KD; AIS; SMAX1; HUMARA; AR
Target/Specificity
Purified recombinant fragment of human AR expressed in E. Coli.
Dilution
WB~~1:500 - 2000.
Format
Purified recombinant fragment of human AR expressed in E. Coli.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
Androgen receptor Antibody is for research use only and not for use in diagnostic or therapeutic procedures.

Androgen receptor Antibody - Protein Information

Name AR
Synonyms DHTR, NR3C4
Function
Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins. Transcription activation is down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3
Cellular Location
Nucleus. Cytoplasm. Note=Predominantly cytoplasmic in unligated form but translocates to the nucleus upon ligand-binding. Can also translocate to the nucleus in unligated form in the presence of GNB2L1
Tissue Location
Isoform 2 is mainly expressed in heart and skeletal muscle

Androgen receptor Antibody - Related products

AP2509a: Androgen Receptor (ANDR) Antibody

AM1824a: NUCL Antibody

AP10111c: AR Antibody (Center)

AP13058c: AR Antibody (Center)

AP13255c: AR Antibody (Center)

RI10361: AR predesign siRNA

BP10111c: AR Antibody (Center) Blocking peptide

AO1218a: AR Antibody

AO1343a: Androgen receptor Antibody

AJ1043a: Androgen Antibody

AF1061a: Androgen Receptor Antibody

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

The androgen receptor (AR), also known as NR3C4 (nuclear receptor subfamily 3, group C, member 4), is a type of nuclear receptor which is activated by binding of either of the androgenic hormones testosterone or dihydrotestosterone in the cytoplasm and then translocating into the nucleus. The androgen receptor is most closely related to the progesterone receptor, and progestins in higher dosages can block the androgen receptor. The main function of the androgen receptor is as a DNA binding transcription factor which regulates gene expression; however, the androgen receptor has other functions as well. Androgen regulated genes are critical for the development and maintenance of the male sexual phenotype.

REFERENCES

1. Chin Med J (Engl). 2009 Nov 20;122(22):2779-83.
2. Taiwan J Obstet Gynecol. 2009 Sep;48(3):262-7.
3. Prostate. 2008 Mar 1;68(4):453-61.
4. Cancer Res. 2007 May 15;67(10):4630-7.